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Abstract
Background: Several studies have been shown pro-apoptotic effects of fish oil (FO), rich in n-3 polyunsaturated
fatty acids (n-3 PUFA) on cancer cells. Nevertheless, few in vivo experiments have provided data of its ability on
apoptosis protein expression in tumor tissue. Thus, in this study we investigate the effect of FO supplementation on
apoptosis protein expression in Walker 256 tumor bearing rats. Male Wistar rats were randomly assigned to three
groups: fed with regular chow (W); fed regular chow supplemented with FO (WFO) or coconut fat (WCO) (1 g/kg
body weight/daily). After thirty days, all animals were inoculated subcutaneously with Walker 256 tumor cells.
Findings: Protein expression was done by western blotting in Walker 256 tumor tissue samples. FO decreased
the Bcl-2/Bax ratio (p < 0.05) and increased the p53 (p < 0.05), cleaved caspase-7 (p < 0.05) and cleaved caspase-3
(p < 0.05) in Walker 256 tumor tissue.
Conclusions: Our data suggest that the pro-apoptotic effect of FO in Walker 256 tumor is related with specifics
cleaved caspases.
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Background
N-3 polyunsaturated fatty acids family presents several
biological properties, including anti-cancer development
and cachexia [1]. We previously reported that adminis-
tration of fish oil (FO), rich in n-3 polyunsaturared fatty
acids (n-3 PUFA), caused reduction of cell proliferation
and increased apoptosis in Walker 256 tumor cells [2].
Apoptosis is an important process of programmed cell
death with precise biochemical and genetic pathways. In
cancer cells, apoptosis is reduced by different mecha-
nisms, which leads to tumor development [3]. The apop-
tosis signaling occurs by several independent routes that
converge to activation of caspases, a family of cysteine
proteases that act as regulators of initiation and execution
of apoptosis. This activation can be controlled by the
Bcl-2 family proteins, which have pro-apoptotic and anti-
apoptotic effects [4, 5]. Furthermore, the p53 protein can
interact with the proteins of Bcl-2 family and induce
apoptosis [6, 7]. The mechanisms underlying n-3 PUFA
pro-apoptotic effect in cancer cells is still unknown.
There are few in vivo experiments providing data on
the ability of FO to alter the apoptosis protein expres-
sion in tumor tissue. In this report, we bring new infor-
mation in this subject once we examinate Bcl-2/Bax
ratio, p53, caspase-7 and caspase-3 protein expression in
Walker 256 tumor tissue after FO administration.
Materials and methods
Animals and study design
All experimental procedures were approved by The Local
Ethics Animal Experiment Committee, and were carried
out in accordance with the ethical principles established
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by the Experimental Brazilian Council (COBEA). Male
Wistar rats 70 days old were maintained under controlled
temperature (22 ± 3 °C), 12 h/12 h light/dark cycle and re-
ceived regular chow diet (Nuvilab CR-1, Nuvital) ad libi-
tum. The content of commercial regular chow indicates:
carbohydrate 63,4 % kcal, protein 25,6 % kcal and lipid
11 % kcal. The animals were randomized into three
groups: Walker 256 tumor-bearing rats fed with regular
chow (W); Walker 256 tumor-bearing rats fed with regu-
lar chow plus fish oil supplementation (WFO) or coconut
fat (WCO). The fish oil was kindly donated by Herbarium
Foundation and the coconut fat was purchased from
Refino de oleos. The fatty acid composition of the chow,
fish oil (FO) and coconut (CO) was determined by high-
performance liquid chromatography (% total fatty acid)
(Table 1). The WFO and WCO groups received 1 g/kg/
day of its respective oils, administered as single bolus
using a micro pipette until the end of experiment (45 days
of supplementation). Body mass from all animals was
monitored every 2 days during the experiment.
Walker 256 tumor cell
Walker 256 tumor is a carcinosarcoma that has been main-
tained in our Laboratory. The tumor cells were obtained
from a rat ascitic fluid by intraperitoneal passages as de-
scribed elsewhere [8]. The percentage of viable cells was
established by trypan blue solution (1 %) using a Neubauer
chamber. When animals reached 100 days of age, all groups
(W; WFO; WCO) were inoculated subcutaneouly in the
right flank with 1 mL of a sterile suspension of 1x108 Walker
tumor cells obtained from an ascitic tumor-bearing rat.
High-performance liquid chromatography
The quantification of fatty acid composition in the chow,
fish oil, coconut fat and tumor tissue was performed
by high-performance liquid chromatography (HPLC) as
described elsewhere [1]. The n-6 PUFA: linoleic acid (LA);
arachidonic acid (AA) and n-3 PUFA: α-linolenic acid
(ALA), eicosapentaenoic acid (EPA), docosahexaenoic acid
(DHA) were used to determined n-6/n-3 PUFA ratio.
Western blotting
Tumor tissue samples (100 mg) were homogenized in lysis
buffer plus protease inhibitor tablet (Sigma-Aldrich).
Protein concentration was determined using Bradford
assay [9]. Sample proteins (45 μg) were loaded onto a
range from 8–15 % Polyacrylamide Gel Electrophoresis
and transferred onto nitrocellulose membrane by electro
blotting under wet conditions (Mini Trans blot Bio-Rad).
The membranes were incubated overnight at 4o C indi-
vidually with the following antibodies: anti-p53, anti-
Bcl-2, anti-Bax, anti-β-actin (Santa Cruz Biotechnology),
anti-caspase-7, anti-cleaved caspase-7, anti-caspase-3,
anti-cleaved caspase-3, anti-PARP-1, anti-cleaved PARP-1
(Cell Signaling Technology) at 1:1000 dilution. Then, they
were incubated with their secondary antibody conjugated
horseradish peroxidase (Santa Cruz Biotechnology) for
two hours at room temperature at 1:6000 dilution. Then
they were exposed to Kodak® film with chemiluminescent
substrate (Super Signal System Pierce) and the resulting
bands were analyzed and quantified by Image J® (National
Institute of Health). β-actin was used as housekeeping.
Statistical analysis
The statistical analysis was performed by one-way ana-
lysis of variance (ANOVA), followed by post hoc Tukey
test, using GraphPad Prism software (GraphPad Inc.).
All data are reported as mean ± standard error of the
mean and value of p < 0.05 was taken to indicate statis-
tical significance.
Table 1 Fatty acid profile of regular chow, FO, CO and tumor tissue
Fatty acids (g/100 g total fatty acids) Regular chow Fish oil Coconut fat Tumor tissue
W WFO WCO
Lauric acid (12:0) 1.3 ± 0.3 4.8 ± 0.1 45.3 ± 3.1 4.6 ± 1.4 2.3 ± 0.4 5.4 ± 1.8
Miristic acid (14:0) - 9.9 ± 0.1 17.0 ± 1.9 1.8 ± 1.8 2.5 ± 1.4 2.2 ± 1.3
Palmitic acid (16:0) 13.7 ± 0.9 16.7 ± 0.2 25.0 ± 2.8 19.2 ± 0.2 16.9 ± 0.2 15.3 ± 0.3
Stearic acid (18:0) 2.4 ± 0.3 1.9 ± 0.3 1.9 ± 0.2 12.6 ± 0.4 5.7 ± 1.2 8.5 ± 1.1
Oleic acid (18:1n-9) 20.0 ± 0.1 10.6 ± 0.1 7.9 ± 0.2 18.9 ± 0.7 22.6 ± 0.2 22.6 ± 0.5
Linoleic acid (18:2n-6) 56.0 ± 0.8 11.6 ± 0.1 2.0 ± 1.2 20.5 ± 0.5 35.4 ± 0.1 33.7 ± 1.1
α -Linolenic acid (18:3n-3) 6.0 ± 0.6 - 0.9 ± 0.1 0.5 ± 0.1 2.0 ± 0.2 1.6 ± 1.5
Arachidonic acid (20:4n-6) 0.3 ± 0.2 0.7 ± 0.1 - 19.0 ± 0.4 6.5 ± 0.3 8.5 ± 0.6
Eicosapentaenoic acid (20:5n-3) 0.2 ± 0.1 23.9 ± 0.6 - 0.3 ± 0.3 2.0 ± 0.7* 0.4 ± 0.3
Docosahexaenoic acid (22:6n-3) - 19.8 ± 0.8 - 2.5 ± 1.1 4.1 ± 1.8* 1.8 ± 1.7
n-6 / n-3 PUFA ratio 9.0 1.4 8.4 12.0 5.2 11.0
Fatty acid composition of regular chow, fish oil (FO), coconut fat (CO) and tumor tissue by high performance liquid chromatographer. Data are mean ± SEM (n = 9)
of Walker 256 tumor-bearing rats (W), Walker 256 tumor-bearing rats supplemented with fish oil (WFO) and coconut fat (WCO) * p < 0.05 vs. W and WCO group
Borghetti et al. Lipids in Health and Disease  (2015) 14:94 Page 2 of 5
Results
FO supplementation decreased the n-6/n-3 PUFA ratio
in tumor tissue by 2 fold (Table 1) and reduced the
tumor weight by 47 % (W 16.9 ± 1.2 vs. WFO 9.0 ± 0.8
vs. WCO 17.1 ± 2.1) (Fig. 1) when compared with
Walker 256 tumor-bearing rats fed with regular chow
group (W) or WCO group (p < 0.05). Tumors from
Walker 256 tumor-bearing rats fed with regular chow
plus fish oil supplementation group (WFO) had a sig-
nificant decrease of 20.3 % (W 1.13 ± 0.03 vs. WFO
0.90 ± 0.03 vs. WCO 1.09 ± 0.03) from Bcl-2/Bax ratio
when compared with W or WCO group (p < 0.05)
(Fig. 2). FO supplementation also increased the protein
expression of p53 by 29 % (W 0.86 ± 0.04 vs. WFO 1.11 ±
0.04 vs. WCO 0.91. ± 0.04) (p < 0.05) (Fig. 3), cleaved
caspase-7 by 21.4 % (W 0.98 ± 0.01 vs. WFO 1.19 ± 0.03
vs. WCO 0.99 ± 0.03) (p < 0.05) (Fig. 4) and cleaved
caspase-3 by 26 % (W 0.92 ± 0.02 vs. WOP 1.16 ± 0.04 vs.
WCO 0.94 ± 0.02) (p < 0.05) (Fig. 5) in tumor tissue
when compared with W and WCO. FO supplementa-
tion did not modify the PARP-1 protein expression in
tumor tissue (W 1.03 ± 0.02 vs. WFO 1.08 ± 0.03 vs.
WCO 1.04 ± 0.05) (Fig. 6). There was no difference in
the tumor protein expression of WCO when compared
with W group (p > 0.05).
Discussion
Previous studies have shown that diets rich in n-3
PUFAs decrease tumor growth in Walker 256 tumor-
bearing rats [1, 2, 10]. The increase of apoptosis by n-3
PUFA is one of the possible mechanisms involved in this
process [2]. Our data support these hypothesis, once FO
supplementation altered the expression of key apoptotic
proteins in the Walker 256 tumor tissue. Furthermore,
literature suggests that n-6/n-3 PUFA ratio reduction
Fig. 1 Tumor growth (g) of Walker 256 tumor-bearing rats (W),
Walker 256 tumor-bearing rats supplemented with fish oil (WFO)
and coconut fat (WCO). Data are mean ± SEM (n = 15) * p < 0.05 vs.
W and WCO group
Fig. 2 Protein expression of Bcl-2/Bax ratio in the Walker 256 tumor
tissue. Anti-β-actin was used as a loading control to normalize the
data. Data are mean ± SEM (n = 7) of Walker 256 tumor-bearing rats
(W), Walker 256 tumor-bearing rats supplemented with fish oil
(WFO) and coconut fat (WCO) * p < 0.05 vs. W and WCO group
Fig. 3 Protein expression of p53 in the Walker 256 tumor tissue.
Anti-β-actin was used as a loading control to normalize the data.
Data are mean ± SEM (n = 7) of Walker 256 tumor-bearing rats (W),
Walker 256 tumor-bearing rats supplemented with fish oil (WFO)
and coconut fat (WCO) * p < 0.05 vs. W and WCO group
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leads to anti-tumor activity [11, 12]. Incorporation of n-
3 PUFA in the tumor cell membrane may change apop-
tosis cell signaling, such as caspase-3 [13]. In addition,
Willliams et al. also showed effects of n-6/n-3 PUFA ra-
tio on prostate tumors [14]. Several studies have sug-
gested that DHA may influence p53 expression,
associated with the activation of caspase-9 and caspase-3
in Reh cells [6]. Besides, n-3 PUFAs may activate im-
portant molecules that signal to carcinogenesis, such as
Bcl-2 family proteins [15–17]. We found that Bcl-2
expression, an antiapoptotic protein, is inversely related
to p53 expression, indicating that the increase of p53
may decrease the Bcl-2 protein, which corroborate with
previous studies [18]. P53 protein expression may also
play an important role in n-3 PUFA’s anti-proliferative
effects. Moreover we did not detect any change in Bax
expression, which is a pro-apoptotic protein. Even with-
out Bax expression alteration, the Bcl-2/Bax ratio was
found lower in the WFO group, which suggests a favor-
able balance to increase apoptosis.
In order to seek further events in the molecular sig-
naling of apoptosis we check the caspases activity in
the Walker 256 tumor. Caspases-7 and caspase-3 are
both executioner caspases and share common roles in
apoptosis, where PARP-1 is the substrate cleaved by
them [19, 20]. During cell death, detection of the
cleaved PARP - 1 is regarded to be a hallmark of apop-
tosis [19, 21]. Members of PARP family can play a role
in both pro - and anti - tumor process, depending on
circumstances. Recent findings have suggested the in-
volvement of PARP-1 on multiple tumorigenesis path-
ways, including cell proliferation and invasion, however,
the exact mechanisms remain unclear [22, 23]. In this
study, we found that FO is involved in the up regulation
of apoptosis in Walker 256 tumor by increasing caspase-7
and caspase-3 activities. Besides PARP-1 is detected dur-
ing apoptotic pathways in various cells’ type. Once our
data did not show difference in PARP-1 expression, it is
possible that PARP-1 activity is also involved in non-
Fig. 4 Protein expression of cleaved caspase-7 in the Walker 256
tumor tissue. Anti-β-actin was used as a loading control to normalize
the data. Data are mean ± SEM (n = 7) of Walker 256 tumor-bearing
rats (W), Walker 256 tumor-bearing rats supplemented with fish oil
(WFO) and coconut fat (WCO) * p < 0.05 vs. W and WCO group
Fig. 5 Protein expression of cleaved caspase-3 in the Walker 256
tumor tissue. Anti-β-actin was used as a loading control to normalize
the data. Data are mean ± SEM (n = 7) of Walker 256 tumor-bearing
rats (W), Walker 256 tumor-bearing rats supplemented with fish oil
(WFO) and coconut fat (WCO) * p < 0.05 vs. W and WCO group
Fig. 6 Protein expression of PAPR-1 in the Walker 256 tumor tissue.
Anti-β-actin was used as a loading control to normalize the data.
Data are mean ± SEM (n = 7) of Walker 256 tumor-bearing rats (W),
Walker 256 tumor-bearing rats supplemented with fish oil (WFO)
and coconut fat (WCO) * p < 0.05 vs. W and WCO group
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apoptotic death pathway in Walker 256 tumor cell.
Although Caspase-3 and Caspase-7 have specifities in
cleaving PARP-1, we propose that others caspases sub-
strates may be involved during the execution of apoptosis.
However, further research is needed to investigate the role
of PARP-1 in Walker 256 tumor cell. Interestingly, we did
not detect the expression of procaspase-3 in Walker 256
tumor by western blotting and studies are currently being
conducted by our group to better understand this feature.
One major limitation of our experimental design is
that we do not know which of the fish oil components is
responsible for our findings in Walker 256 tumor. The
beneficial effects of fish oil seem to be due to its high
content of n-3 PUFA (combined: DHA and EPA) and
the decrease of n-6/n-3 PUFA ratio. However, the mo-
lecular mechanisms by which DHA or EPA alone may
affect the Walker 256 tumor is still unclear and need
future studies.
Conclusions
In summary, our findings suggest that FO induce apop-
tosis by p53, Bcl-2, caspase-7 and caspase-3, but not Bax
and PARP-1 in Walker 256 tumor. This pro-apoptotic
effect is related with caspase pathways and may be also
associated with reduction of n-6/n-3 PUFA ratio.
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